Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

MDRX PEER ANALYSIS

Veradigm Inc. — metric-by-metric comparison with peers and the industry median

MDRXVeradigm Inc.

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Health Information Services

Return Comparison

1-Year
Split-adjusted
MDRX+13.3%FONET+128.7%PME-30.3%
Year-to-Date (YTD)
MDRX+6.3%FONET+88.2%PME-2.9%
1-Year
Split-adjusted
MDRX+13.3%EVH-51.3%PHR-61.7%WEAV-23.8%HSTM+5.2%NRC+35.8%
Year-to-Date (YTD)
MDRX+6.3%EVH+43.5%PHR-34.4%WEAV-11.7%HSTM+26.4%NRC+21.0%

Key Metric Comparison

P/E

Lower is better
MDRX—FONET20.21PME95.33Median 42.94

ROE

Higher is better
MDRX—FONET15.6%PME76.8%Median 2.7%

Net Margin

Higher is better
MDRX—FONET26.0%PME97.6%Median 1.5%

Revenue Growth

Higher is better
MDRX—FONET53.5%PME30.3%Median 7.1%

P/E

Lower is better
MDRX—EVH—PHR74.99WEAV—HSTM42.94NRC54.57Median 42.94

ROE

Higher is better
MDRX—EVH-74.6%PHR2.9%WEAV-32.9%HSTM5.6%NRC41.9%Median 2.7%

Net Margin

Higher is better
MDRX—EVH-26.3%PHR1.9%WEAV-10.1%HSTM6.4%NRC6.5%Median 1.5%

Revenue Growth

Higher is better
MDRX—EVH-21.3%PHR14.1%WEAV16.8%HSTM6.6%NRC-1.9%Median 7.1%

All Metrics

Valuation
MetricMDRXFONETPMEInd. Median
P/E—20.21●95.3342.94
P/B—2.62●57.532.52
EV/EBITDA—10.38●117.5216.31
P/S—5.26●93.002.40
Financial Health
MetricMDRXFONETPMEInd. Median
Current Ratio—2.316.22●1.83
Debt/Equity—2.5%1.1%●22.0%
NetDebt/EBITDA—-0.21-1.16●-0.01
Profitability
MetricMDRXFONETPMEInd. Median
Net Margin—26.0%97.6%●1.5%
ROE—15.6%76.8%●2.7%
ROA—13.2%56.7%●1.4%
EBITDA Margin—49.6%78.4%●12.4%
Growth + Dividend
MetricMDRXFONETPMEInd. Median
Rev. Growth—53.5%●30.3%7.1%
NI Growth—26.6%138.8%●23.6%
Div. Yield—0.0%0.3%●0.7%
Payout—0.0%24.5%9.6%
Valuation
MetricMDRXEVHPHRWEAVHSTMNRCInd. Median
P/E——74.99—42.94●54.5742.94
P/B—1.62●1.926.322.4336.532.52
EV/EBITDA——16.65—11.49●20.4016.31
P/S—0.34●1.392.122.743.562.40
Financial Health
MetricMDRXEVHPHRWEAVHSTMNRCInd. Median
Current Ratio—1.321.76●1.240.970.521.83
Debt/Equity—248.6%25.8%61.6%4.0%●578.2%22.0%
NetDebt/EBITDA—-2.61●0.422.86-0.752.71-0.01
Profitability
MetricMDRXEVHPHRWEAVHSTMNRCInd. Median
Net Margin—-26.3%1.9%-10.1%6.4%6.5%●1.5%
ROE—-74.6%2.9%-32.9%5.6%41.9%●2.7%
ROA—-21.9%1.7%-12.7%3.8%6.7%●1.4%
EBITDA Margin—-16.7%8.6%-3.0%22.4%●20.1%12.4%
Growth + Dividend
MetricMDRXEVHPHRWEAVHSTMNRCInd. Median
Rev. Growth—-21.3%14.1%16.8%●6.6%-1.9%7.1%
NI Growth————4.2%●-62.7%23.6%
Div. Yield—1.0%——0.5%2.5%●0.7%
Payout—-1.3%——19.1%131.0%9.6%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MDRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jun 26, 26. This content is for informational purposes only and is not investment advice.